EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Different eGFR markers and prediction of cardiovascular risk

Maria Tydén iD, Gorav Batra, Bengt Fellström, Claes Held, Johan Lindbäck, Inga Soveri, Maria K Svensson, Ralph Stewart, Harvey D White, Lars Wallentin

Journal of Internal Medicine · 2026-01 · 299 (1) · 143-157

DOI: 10.1111/joim.70050 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Internal Medicine, online erschienen am 22.11.2025. Verfasst von Maria Tydén und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Renal Medicine, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Glomerular Filtration Rate, Cystatin C, Cardiovascular Diseases, Creatinine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renal dysfunction increases cardiovascular (CV) risk. We compared cystatin C‐based estimated glomerular filtration rate (eGFRcys), creatinine‐based eGFR (eGFRcr), and their ratio (eGFRcys/eGFRcr) in relation to major adverse cardiovascular events (MACE) and all‐cause mortality in chronic coronary syndrome, assessing the added prognostic value of the eGFRratio.

Methods

In this post hoc analysis of 14,513 Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy trial patients, we investigated associations between baseline eGFRcys, eGFRcr, their ratio, and MACE and all‐cause death using Cox regression models, unadjusted and adjusted for eGFRcys, eGFRcr, and their combination. Discrimination was assessed using Harrell's C ‐index; added value by the fraction of new information (FNI).

Results

Median age was 65 years; 82% were male. Median eGFRcys was 77 (interquartile range [IQR]: 61–94) and eGFRcr 79 (IQR: 65–91) mL/min/1.73 m 2 . Over 3.7 years, 1449 MACE and 1063 deaths occurred. Lower eGFR values and eGFRratio were associated with increased MACE risk, primarily driven by CV death. For eGFRcys 60 versus 90, the hazard ratio (HR) for MACE adjusted for eGFRcr was 1.77 (95% CI: 1.49–2.09, FNI 54%). In contrast, eGFRcr adjusted for eGFRcys showed no positive association (HR 0.82, 95% CI: 0.68–0.97, FNI 3%). A lower eGFRratio was linked to higher MACE risk (HR 1.99, 95% CI: 1.80–2.21), which remained after eGFRcr adjustment (HR 1.89, 95% CI: 1.70–2.10, FNI 54%) but was attenuated after eGFRcys adjustment (HR 1.29, 95% CI: 1.13–1.46, FNI 5%).

Conclusion

In chronic coronary syndrome, lower eGFRcys, eGFRcr, and eGFRratio were associated with higher MACE and mortality risk. eGFRcys had the strongest association; eGFRcr and eGFRratio added limited incremental value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerular Filtration RateCystatin CCardiovascular DiseasesCreatinineHumansMaleFemaleAgedMiddle AgedBiomarkersAged, 80 and overPrognosisOximesRisk AssessmentHeart Disease Risk FactorsRisk FactorsBiphenyl CompoundsDiethylaminesPyrimidinonesSulfides

Stichwörter der Autor:innen

Keywordscardiovascular eventscreatininecystatin Cglomerular filtration ratemortality

Substanzen

Cystatin CBiomarkersCreatininedarapladibOximesBiphenyl CompoundsDiethylaminesPyrimidinonesSulfides

Autor:innen und Institutionen

  • Department of Medical Sciences, Renal Medicine, Uppsala University, Uppsala, Sweden.
  • Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
  • Uppsala Clinical Research Center (UCR), Uppsala University, Uppsala, Sweden.
  • Green Lane Cardiovascular Service, Auckland City Hospital and Auckland University, Auckland, New Zealand.

ORCID-Profile: Maria Tydén

Zitieren

APA

Tydén, M., Batra, G., Fellström, B., Held, C., Lindbäck, J., Soveri, I., Svensson, M. K., Stewart, R., White, H. D., & Wallentin, L. (2026). Different eGFR markers and prediction of cardiovascular risk. Journal of Internal Medicine, 299(1), 143-157. https://doi.org/10.1111/joim.70050

Vancouver

Tydén M, Batra G, Fellström B, Held C, Lindbäck J, Soveri I, et al. Different eGFR markers and prediction of cardiovascular risk. Journal of Internal Medicine. 2026;299(1):143-157. doi:10.1111/joim.70050

BibTeX
@article{Tydn2026,
  author = {Tydén, Maria and Batra, Gorav and Fellström, Bengt and Held, Claes and Lindbäck, Johan and Soveri, Inga and Svensson, Maria K and Stewart, Ralph and White, Harvey D and Wallentin, Lars},
  title = {Different eGFR markers and prediction of cardiovascular risk},
  journal = {Journal of Internal Medicine},
  year = {2026},
  volume = {299},
  number = {1},
  pages = {143--157},
  doi = {10.1111/joim.70050}
}
Kostenlos starten →